|
ENTO
|
Entero Therapeutics, Inc.
|
US
|
US
|
|
ENTX
|
Entera Bio Ltd.
|
US
|
NASDAQ
|
|
ENZN
|
Enzon Pharma Inc
|
US
|
OTC
|
|
EPIX
|
ESSA Pharma Inc.
|
US
|
NASDAQ
|
|
EPRSQ
|
EPIRUS Biopharmaceuticals Inc
|
US
|
US
|
|
EPRX
|
Eupraxia Pharmaceuticals Inc. Common Stock
|
US
|
US
|
|
EQ
|
Equillium, Inc.
|
US
|
NASDAQ
|
|
ERYP
|
Erytech Pharma
|
FR
|
PA
|
|
ESPR
|
Esperion Therapeutics, Inc.
|
US
|
NASDAQ
|
|
EVG
|
Evgen Pharma Plc
|
UK
|
LSE
|
|
EVGN
|
Evogene
|
US
|
NASDAQ
|
|
EVGN
|
Evogene
|
IL
|
TA
|
|
EVLO
|
Evelo Biosciences, Inc.
|
US
|
NASDAQ
|
|
EXAS
|
Exact Sciences Corporation
|
US
|
NASDAQ
|
|
EXEL
|
Exelixis, Inc.
|
US
|
NASDAQ
|
|
FARN
|
Faron Pharmaceuticals Oy
|
UK
|
LSE
|
|
FATE
|
Fate Therapeutics, Inc.
|
US
|
NASDAQ
|
|
FBIO
|
Fortress Biotech, Inc.
|
US
|
NASDAQ
|
|
FENC
|
Fennec Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
FGEN
|
FibroGen, Inc
|
US
|
NASDAQ
|